Chemed Corp (CHE)
488.10
+2.03 (+0.42%)
USD |
NYSE |
May 20, 16:00
488.06
-0.04 (-0.01%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 7.306B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -2.66% |
| Valuation | |
| PE Ratio | 28.56 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.568 |
| Price to Book Value | 10.96 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.36 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.18 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 30.63% |
News
Headline
Wire
Time (ET)
MT Newswires
05/16 14:17
Yahoo
05/16 14:13
Yahoo
05/11 12:00
Yahoo
05/03 12:00
MT Newswires
04/28 08:04
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 07/28/2022* | 10:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 07/27/2022* | -- | Results | Q2 2022 | -- | 4.78 | -- | |
| 04/27/2022 | 10:00 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 04/26/2022 | -- | Results | Q1 2022 | 4.79 | 4.47 | 7.08% | |
| 02/25/2022 | 10:00 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 02/24/2022 | -- | Results | Q4 2021 | 5.25 | 5.08 | 3.41% | |
| 10/29/2021 | 10:00 EST | Earnings Call | Q3 2021 | -- | -- | -- | |
| 10/28/2021 | -- | Results | Q3 2021 | 5.06 | 4.49 | 12.69% |
*Estimated Date/Time
Earnings
Profile
Edit
| Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States. |
| URL | https://www.chemed.com |
| Investor Relations URL | https://ir.chemed.com |
| HQ State/Province | Ohio |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Jul. 27, 2022 (est.) |
| Last Earnings Release | Apr. 26, 2022 |
| Next Ex-Dividend Date | May. 25, 2022 |
| Last Ex-Dividend Date | Feb. 25, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 1.42 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.2195 |
| Yield to Sector | 0.1514 |
| Yield to Industry | 0.1381 |
| Last Dividend Amt. | 0.36 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Feb. 25, 2022 |
| Yield (TTM) | 0.29% |
| Forward Yield | 0.30% |
| Payout Ratio | 8.19% |
| Cash Payout Ratio | 8.78% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of May 20, 2022.
Fundamentals
| Revenue (TTM) | 2.142B |
| Total Expenses (TTM) | 1.786B |
| Net Income (TTM) | 267.32M |
| Total Assets (Quarterly) | 1.306B |
| Total Liabilities (Quarterly) | 639.05M |
| Shareholders Equity (Quarterly) | 666.70M |
| Cash from Operations (TTM) | 302.97M |
| Cash from Investing (TTM) | -54.28M |
| Cash from Financing (TTM) | -440.68M |
Ratings
Profile
Edit
| Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States. |
| URL | https://www.chemed.com |
| Investor Relations URL | https://ir.chemed.com |
| HQ State/Province | Ohio |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Jul. 27, 2022 (est.) |
| Last Earnings Release | Apr. 26, 2022 |
| Next Ex-Dividend Date | May. 25, 2022 |
| Last Ex-Dividend Date | Feb. 25, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| CCRIX | 74.73M USD | 3.43% |
| OSCV | 4.433M USD | 2.54% |
| JSMD | 3.771M USD | 2.41% |
| CSCCX | 69.92M USD | 2.16% |
| XMHQ | 5.915M USD | 1.91% |
| NBGAX | 181.16M USD | 1.61% |
| LIACX | 56.41M USD | 1.56% |
| ADME | 5.236M USD | 1.54% |
| JSEQX | 97.12M USD | 1.39% |
| IHF | 19.84M USD | 1.33% |
| JGMCX | 114.26M USD | 1.20% |
| SMLF | 8.247M USD | 0.87% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| CHE Tweets |